The Baseline Tumor Size is an independent prognostic Factor for the progression-free but not the Overall Survival after Ipilimumab in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Angelova, D. [1 ]
Weide, B. [2 ]
Heppt, M. [3 ]
Berking, C. [3 ]
Tietze, J. [1 ]
机构：
[1] Klinikum Augsburg, Dermatol, Augsburg, Germany
[2] Univ Hautklin Tubingen, Dermatol, Tubingen, Germany
[3] Ludwig Maximilians Univ Munchen, Dermatol, Munich, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P125
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [41] Association of Progression-Free Survival With Overall Survival in Patients With Neuroendocrine Tumor Treated With Somatostatin Analogs
    Ter-Minassian, Monica
    Brooks, Nichole V.
    Brais, Lauren K.
    Chan, Jennifer A.
    Christiani, David C.
    Lin, Xihong
    Gabriel, Sylvie
    Dinet, Jerome
    Kulke, Matthew H.
    PANCREAS, 2016, 45 (03) : 483 - 483
  • [42] Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?
    Chiaravalloti, Agostino
    Esposito, Vincenzo
    Ursini, Francesco
    Di Giorgio, Eugenio
    Zinzi, Maddalena
    Calabria, Ferdinando
    Cimini, Andrea
    Schillaci, Orazio
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (07) : 471 - 480
  • [43] Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?
    Agostino Chiaravalloti
    Vincenzo Esposito
    Francesco Ursini
    Eugenio Di Giorgio
    Maddalena Zinzi
    Ferdinando Calabria
    Andrea Cimini
    Orazio Schillaci
    Annals of Nuclear Medicine, 2019, 33 : 471 - 480
  • [44] Extended adjuvant temozolamide as prognostic factor of longer overall and progression-free survival in glioblastoma multiforme
    Povoa, S. C.
    Tavares, N.
    Ribeiro, M. J.
    Azevedo, D.
    Coelho, A.
    Fernandes, A.
    Costa, A.
    Caeiro, C.
    Carvalho, B.
    Linhares, P.
    Osorio, L.
    Castro, L.
    Fonseca, J.
    Damasceno, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] Overall and progression-free survival in metastatic basosquamous cancer: A case series
    Zhu, Gefei Alex
    Danial, Christina
    Liu, Andy
    Li, Shufeng
    Chang, Anne Lynn Su
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (06) : 1145 - 1146
  • [46] Overall survival in patients with metastatic melanoma treated with concurrent ipilimumab and radiotherapy
    Koller, Kristian Michael
    Mackley, Heath B.
    Wagner, Henry
    Talamo, Giampaolo
    Schell, Todd
    Pameijer, Colette
    Neves, Rogerio Izar
    Anderson, Bryan
    Kokolus, Kathleen M.
    Mallon, Carol
    Drabick, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [48] Hepatic Progression Free and Overall Survival after Regional Therapy to the Liver for Metastatic Melanoma
    Abbott, A. M.
    Kim, Y.
    Gandle, C.
    Rashid, O. M.
    Fulp, W. J.
    Thomas, K.
    Gibney, G.
    Weber, J.
    Choi, J.
    Shridhar, R.
    Zager, J.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S125 - S126
  • [49] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
  • [50] Impact of baseline proteinuria on progression-free survival after regorafenib treatment for metastatic colorectal cancer
    Yoshitaka Saito
    Yoh Takekuma
    Yoshito Komatsu
    Mitsuru Sugawara
    Supportive Care in Cancer, 2025, 33 (5)
12345